Anthony V. D'Amico, MD, PHD

Dana-Farber Cancer Institute and (Sanofi-Aventis ...Boston, Massachusetts - 02115 (617-632-6328) |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS3
- SINCE2005

Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
June 2005 - June 2014
Prostatic Neoplasms
Docetaxel
Androgen Hormonal Suppression And Radiation
Androgen Suppression Therapy And Radiation Therapy



